Vijay R. More, Ph.D. - Publications

Affiliations: 
2013 Pharmaceutical Sciences University of Rhode Island, Providence, RI, United States 
Area:
Pharmacology, Toxicology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 More VR, Lao J, McLaren DG, Cumiskey AM, Murphy BA, Chen Y, Previs S, Stout S, Patel R, Satapati S, Li W, Kowalik E, Szeto D, Nawrocki A, Pocai A, et al. Glucagon like receptor 1/ glucagon dual agonist acutely enhanced hepatic lipid clearance and suppressed de novo lipogenesis in mice. Plos One. 12: e0186586. PMID 29065174 DOI: 10.1371/Journal.Pone.0186586  0.48
2017 Shimpi PC, More VR, Paranjpe M, Donepudi AC, Goodrich JM, Dolinoy DC, Rubin B, Slitt AL. Hepatic Lipid Accumulation and Nrf2 Expression following Perinatal and Peripubertal Exposure to Bisphenol A in a Mouse Model of Nonalcoholic Liver Disease. Environmental Health Perspectives. 125: 087005. PMID 28796629 DOI: 10.1289/Ehp664  0.726
2016 More VR, Campos CR, Evans RA, Oliver KD, Chan GN, Miller DS, Cannon RE. PPAR-α, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 27193034 DOI: 10.1177/0271678X16650216  0.385
2015 Hoque MT, Shah A, More V, Miller DS, Bendayan R. In Vivo and Ex Vivo Regulation of Breast Cancer Resistant Protein (Bcrp) by Peroxisome Proliferator-Activated Receptor Alpha (Pparα) at the Blood-Brain Barrier. Journal of Neurochemistry. PMID 26465636 DOI: 10.1111/Jnc.13389  0.365
2015 Xu J, Donepudi AC, More VR, Kulkarni SR, Li L, Guo L, Yan B, Chatterjee T, Weintraub N, Slitt AL. Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice. Obesity (Silver Spring, Md.). 23: 335-44. PMID 25451536 DOI: 10.1002/Oby.20929  0.693
2013 Yalcin EB, More V, Neira KL, Lu ZJ, Cherrington NJ, Slitt AL, King RS. Downregulation of sulfotransferase expression and activity in diseased human livers. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1642-50. PMID 23775849 DOI: 10.1124/Dmd.113.050930  0.714
2013 More VR, Xu J, Shimpi PC, Belgrave C, Luyendyk JP, Yamamoto M, Slitt AL. Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding. Free Radical Biology & Medicine. 61: 85-94. PMID 23507082 DOI: 10.1016/J.Freeradbiomed.2013.03.007  0.709
2013 More VR, Cheng Q, Donepudi AC, Buckley DB, Lu ZJ, Cherrington NJ, Slitt AL. Alcohol cirrhosis alters nuclear receptor and drug transporter expression in human liver. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 1148-55. PMID 23462698 DOI: 10.1124/Dmd.112.049676  0.724
2013 Hardwick RN, Ferreira DW, More VR, Lake AD, Lu Z, Manautou JE, Slitt AL, Cherrington NJ. Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 554-61. PMID 23223517 DOI: 10.1124/Dmd.112.048439  0.69
2013 Chen Y, Song X, Valanejad L, Vasilenko A, More V, Qiu X, Chen W, Lai Y, Slitt A, Stoner M, Yan B, Deng R. Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma. Hepatology (Baltimore, Md.). 57: 1530-41. PMID 23213087 DOI: 10.1002/Hep.26187  0.606
2012 Xu J, Kulkarni SR, Donepudi AC, More VR, Slitt AL. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice. Diabetes. 61: 3208-18. PMID 22936178 DOI: 10.2337/Db11-1716  0.694
2012 More VR, Wen X, Thomas PE, Aleksunes LM, Slitt AL. Severe diabetes and leptin resistance cause differential hepatic and renal transporter expression in mice. Comparative Hepatology. 11: 1. PMID 22524730 DOI: 10.1186/1476-5926-11-1  0.644
2011 More VR, Slitt AL. Alteration of hepatic but not renal transporter expression in diet-induced obese mice. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 992-9. PMID 21430232 DOI: 10.1124/Dmd.110.037507  0.73
Show low-probability matches.